122 related articles for article (PubMed ID: 9495606)
1. Pretreatment plasma HVA predicts neuroleptic response in manic psychosis.
Mazure CM; Bowers MB
J Affect Disord; 1998 Feb; 48(1):83-6. PubMed ID: 9495606
[TBL] [Abstract][Full Text] [Related]
2. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
Mazure CM; Nelson JC; Jatlow PI; Bowers MB
Biol Psychiatry; 1991 Sep; 30(5):475-82. PubMed ID: 1932395
[TBL] [Abstract][Full Text] [Related]
3. Plasma catecholamine metabolites and treatment response at neuroleptic steady state.
Bowers MB; Swigar ME; Jatlow PI; Hoffman FJ
Biol Psychiatry; 1989 Mar; 25(6):734-8. PubMed ID: 2923935
[TBL] [Abstract][Full Text] [Related]
4. Psychotogenic drug use and neuroleptic response.
Bowers MB; Mazure CM; Nelson JC; Jatlow PI
Schizophr Bull; 1990; 16(1):81-5. PubMed ID: 1970670
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment plasma HVA and haloperidol response in acute mania.
Chou JC; Czobor P; Tuma I; Charles O; Bebe R; Cooper TB; Chang WH; Lane HY; Stone DL
J Affect Disord; 2000 Jul; 59(1):55-9. PubMed ID: 10814771
[TBL] [Abstract][Full Text] [Related]
6. Lithium in combination with perphenazine: effect on plasma monoamine metabolites.
Bowers MB; Mazure CM; Nelson JC; Jatlow PI
Biol Psychiatry; 1992 Dec; 32(12):1102-7. PubMed ID: 1477190
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of neuroleptics on unmedicated schizophrenic patients and controls.
Miller AL; Maas JW; Contreras S; Seleshi E; True JE; Bowden C; Castiglioni J
Biol Psychiatry; 1993 Aug; 34(3):178-87. PubMed ID: 8104509
[TBL] [Abstract][Full Text] [Related]
8. Plasma catecholamine metabolites as markers for psychosis and antipsychotic response in schizophrenia.
Kelley ME; Yao JK; van Kammen DP
Neuropsychopharmacology; 1999 Jun; 20(6):603-11. PubMed ID: 10327429
[TBL] [Abstract][Full Text] [Related]
9. Early neuroleptic response in psychotic men and women: correlation with plasma HVA and MHPG.
Bowers MB; Swigar ME; Jatlow PI; Hoffman F; Giocoechea N
Compr Psychiatry; 1986; 27(3):181-5. PubMed ID: 2872015
[No Abstract] [Full Text] [Related]
10. Recent life stressors and biological markers in newly admitted psychotic patients.
Mazure CM; Quinlan DM; Bowers MB
Biol Psychiatry; 1997 Apr; 41(8):865-70. PubMed ID: 9099413
[TBL] [Abstract][Full Text] [Related]
11. Evolution of plasma homovanillic acid (HVA) in chronic schizophrenic patients treated with haloperidol.
Galinowski A; Poirier MF; Aymard N; Leyris A; Beauverie P; Bourdel MC; Loo H
Acta Psychiatr Scand; 1998 Jun; 97(6):458-66. PubMed ID: 9669519
[TBL] [Abstract][Full Text] [Related]
12. Etiologic heterogeneity of the psychoses: is there a dopamine psychosis?
Garver DL; Steinberg JL; McDermott BE; Yao JK; Ramberg JE; Lewis S; Kingsbury SJ
Neuropsychopharmacology; 1997 Mar; 16(3):191-201. PubMed ID: 9138435
[TBL] [Abstract][Full Text] [Related]
13. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
Davila R; Gonzalez MA; Zumarraga M; Andia I; Guimon J; Silva RR; Friedhoff AJ
Biol Psychiatry; 1995 Aug; 38(4):267-9. PubMed ID: 8547450
[No Abstract] [Full Text] [Related]
14. Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics.
Kim YK; Kim L; Lee MS
Schizophr Res; 2000 Sep; 44(3):165-75. PubMed ID: 10962218
[TBL] [Abstract][Full Text] [Related]
15. Plasma catecholamine metabolites and early response to haloperidol.
Bowers MB; Swigar ME; Jatlow PI; Goicoechea N
J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216
[TBL] [Abstract][Full Text] [Related]
16. Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium.
Yoshimura R; Ueda N; Shinkai K; Nakamura J
Pharmacopsychiatry; 2006 Nov; 39(6):233-4. PubMed ID: 17124648
[TBL] [Abstract][Full Text] [Related]
17. Correlates of early neuroleptic response using a uniform haloperidol dose.
Bowers MB; Swigar ME; Jatlow PI; Hoffman FJ; Goicoechea N
Int Clin Psychopharmacol; 1987 Jul; 2(3):255-60. PubMed ID: 3693868
[TBL] [Abstract][Full Text] [Related]
18. Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol.
Brown AS; Gewirtz G; Harkavy-Friedman J; Cooper T; Brébion G; Amador XF; Malaspina D; Gorman JM
Neuropsychopharmacology; 1997 Nov; 17(5):317-25. PubMed ID: 9348547
[TBL] [Abstract][Full Text] [Related]
19. The noradrenaline metabolite MHPG is a candidate biomarker from the manic to the remission state in bipolar disorder I: a clinical naturalistic study.
Kurita M; Nishino S; Numata Y; Okubo Y; Sato T
PLoS One; 2014; 9(6):e100634. PubMed ID: 24971450
[TBL] [Abstract][Full Text] [Related]
20. Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders.
Yoshimura R; Nakano Y; Hori H; Ikenouchi A; Ueda N; Nakamura J
Hum Psychopharmacol; 2006 Oct; 21(7):433-8. PubMed ID: 17029305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
